ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 26

Single B Cell Analysis Revealed the Relationship Among the Cytokine Profile, Antibody Affinity, and Pathogenic Roles of Autoantigen-Reactive B Cells in Systemic Sclerosis

Takemichi Fukasawa1, Ayumi Yoshizaki2, Satoshi Ebata1, Kouki Nakamura1, Ryosuke Saigusa1, Takashi Yamashita1, Yoshihide Asano3, Yutaka Kazoe4, Kazuma Mawatari4, Takehiko Kitamori4 and Shinichi Sato5, 1Dermatology, University of Tokyo, Graduate School of Medicine, Tokyo, Japan, 2Department of Dermatology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan, 3Applied Chemistry, University of Tokyo, Graduate School of Medicine, Tokyo, Japan, 4Applied Chemistry, University of Tokyo, Graduate School of Engineering, Tokyo, Japan, 5Department of Dermatology, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Japan

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: autoantibodies, autoantigens, B cells, mouse model and systemic sclerosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 5, 2017

Title: B Cell Biology and Targets in Autoimmune Disease Poster

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:

Recent studies have indicated that B cells play critical roles in systemic autoimmunity and disease expression through various functions such as induction of the activation of other immune cells in addition to autoantibody production. Indeed, rituximab, a B cell depleting antibody, can ameliorate some autoimmune diseases including systemic sclerosis (SSc). However, the role of autoreactive B cells is still not clear, because the number of autoreactive B cells is too small to study their functions directly. Although several studies have revealed that B cells play crucial roles in SSc development, autoreactive B cell functions remain totally unclear. In this study, we investigated the role of autoreactive B cells directly using our original micro-ELISA system, which integrates immunoassay into a microchip in order to detect extremely small amounts of analytes and can study autoreactive B cells at a single cell level.

Methods:

Peripheral blood mononuclear cells (PBMCs) were obtained from topoisomerase (topo) I positive SSc patients and healthy controls. Each of topo I-specific B cells was sorted into individual wells of 96 well plates. Their mRNA levels were assessed by single cell PCR. In addition, their cytokine production was analyzed by the micro-ELISA system which realized the analysis of cytokine production in single cells. In mouse studies, we assessed antibody affinities and cytokine production of topo I-specific B cells using topo I and complete Freund’s adjuvant-induced SSc model mice. Furthermore, topo I-specific B cells from topo I and complete Freund’s adjuvant-induced SSc model mice were adoptively transferred to these model mice and then skin and lung fibrosis was assessed.

Results:

Topo I-specific B cells from SSc patients produced higher amounts of IL-6 compared with topo I-non-specific B cells. In addition, IL-10 production of topo I-specific B cells was lower than those of topo I-non-specific B cells.

To reveal the relationship between B cell affinity to the autoantigen and their cytokine production, we analyzed single topo I-immunized SSc model mice and fourth immunized SSc model mice. Single immunized mice had higher frequencies of IL-10-producing topo I-specific B cells than fourth immunized mice, while fourth immunized mice had higher frequencies of IL-6-producing topo I-specific B cells than single immunized mice. The affinity of topo I-specific B cells from fourth immunized mice was higher than those from single immunized mice. Adoptive transfer with high-affinity topo I-specific B cells aggravated skin and lung fibrosis. By contrast, that with low-affinity topo I-specific B cells ameliorated skin and lung fibrosis.

Conclusion:

These results suggest that distinct B cell cytokine production is determined by B cell autoantigen affinity. Autoantigen-reactive B cells with higher autoantigen affinity can be a novel therapeutic target in SSc.


Disclosure: T. Fukasawa, None; A. Yoshizaki, None; S. Ebata, None; K. Nakamura, None; R. Saigusa, None; T. Yamashita, None; Y. Asano, None; Y. Kazoe, None; K. Mawatari, None; T. Kitamori, None; S. Sato, None.

To cite this abstract in AMA style:

Fukasawa T, Yoshizaki A, Ebata S, Nakamura K, Saigusa R, Yamashita T, Asano Y, Kazoe Y, Mawatari K, Kitamori T, Sato S. Single B Cell Analysis Revealed the Relationship Among the Cytokine Profile, Antibody Affinity, and Pathogenic Roles of Autoantigen-Reactive B Cells in Systemic Sclerosis [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/single-b-cell-analysis-revealed-the-relationship-among-the-cytokine-profile-antibody-affinity-and-pathogenic-roles-of-autoantigen-reactive-b-cells-in-systemic-sclerosis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/single-b-cell-analysis-revealed-the-relationship-among-the-cytokine-profile-antibody-affinity-and-pathogenic-roles-of-autoantigen-reactive-b-cells-in-systemic-sclerosis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology